Biosimilars Leading Russian pharmaceutical producers plan active expansion in the European Union and the US markets over the next several years, which is expected to take place through the launch of new, original drugs, according to an official spokesman of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 16 December 2015